LUKE EVNIN
CIK 1134657 · Chief Executive Officer · last filed 2026-07-08
LUKE EVNIN is a Chief Executive Officer who has filed 108 SEC Form 4 insider transactions across 21 companies since 2007. The most recent filing shows the insider sold $44.7K of HOWL on Jul 8, 2026. Across all open-market trades the lifetime net is −$185.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $636.4M across reported positions. 164 SEC filings were submitted jointly with ANSBERT GADICKE.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$636.43M
21
108
-$185.50M
Filer Profile
SUITE 1100
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HOWL | Director | 107,429 | $0.96 | $103.7K | -$845.3K | 38 | 2026-07-08 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | 10%+ Owner | 3,674,978 | $1.48 | $5.44M | -$263.8K | 1 | 2023-05-24 |
| Oncorus, Inc. (ONCR) Delisted | Director | 2,492,843 | $0.12 | $300.5K | $2.27M | 3 | 2022-06-24 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | 10%+ Owner | 3,377,687 | $10.15 | $34.28M | -$31.71M | 2 | 2021-09-23 |
| TURMERIC ACQUISITION CORP. (TMPMW) Delisted | Chief Executive Officer | — | $0.00 | — | $0 | 1 | 2021-04-30 |
| TURMERIC ACQUISITION CORP. (TMPMU) Delisted | Chief Executive Officer | 415,500 | $9.99 | $4.15M | $0 | 1 | 2020-10-20 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Director | 427,595 | $23.01 | $9.84M | $3.50M | 4 | 2020-06-01 |
| SNDX | Director | 1,138,210 | $18.23 | $20.76M | $0 | 5 | 2018-05-25 |
| RYTM | 10%+ Owner | 2,596,392 | $98.32 | $255.28M | $10.20M | 1 | 2017-10-11 |
| Radius Health, Inc. (RDUS) Delisted | 10%+ Owner | 3,887,502 | $30.00 | $116.63M | $0 | 2 | 2016-09-29 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | 10%+ Owner | 37,117 | — | — | -$108.11M | 1 | 2014-03-12 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 2,413,819 | $1.47 | $3.55M | -$27.30M | 1 | 2014-02-11 |
| ReShape Weightloss Inc. (ETRM) Delisted | Director | 1,397,699 | — | — | $4.25M | 14 | 2014-01-09 |
| PCRX | Director | 844,566 | $25.19 | $21.27M | -$33.62M | 16 | 2013-06-13 |
| MBRX | Director | 2,108 | $0.61 | $1.3K | $168.2K | 4 | 2009-06-25 |
| OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted | 10%+ Owner | 4,222 | — | — | $0 | 1 | 2009-05-29 |
| Pharmasset Inc (VRUS) Delisted | 10%+ Owner | 8,591 | — | — | -$24.60M | 4 | 2008-06-24 |
| PCS | 10%+ Owner | 3,080,596 | $49.14 | $151.40M | $0 | 1 | 2007-04-26 |
| SENORX INC (SENO) Delisted | 10%+ Owner | 2,242,379 | — | — | $0 | 1 | 2007-04-03 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | 3,853,102 | $1.95 | $7.51M | $0 | 1 | 2007-02-15 | |
| MEMY | 10%+ Owner | 11,391,019 | $16.47 | $187.62M | $20.56M | 1 | 2007-01-05 |
Recent Filings
108 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-08 | HOWL | Sell (S) | −143,199 | -$44.7K | EDGAR |
| 2026-06-29 | HOWL | Sell (S) | −157,084 | -$47.1K | EDGAR |
| 2026-06-10 | HOWL | Sell (S) | −76,928 | -$28.5K | EDGAR |
| 2026-06-08 | HOWL | Sell (S) | −105,565 | -$43.0K | EDGAR |
| 2026-06-03 | HOWL | Sell (S) | −139,803 | -$63.6K | EDGAR |
| 2026-05-29 | HOWL | Sell (S) | −141,106 | -$66.2K | EDGAR |
| 2026-05-26 | HOWL | Sell (S) | −191,762 | -$86.6K | EDGAR |
| 2026-05-20 | HOWL | Sell (S) | −171,049 | -$76.4K | EDGAR |
| 2026-05-13 | HOWL | Sell (S) | −44,679 | -$24.1K | EDGAR |
| 2026-05-12 | HOWL | Sell (S) | −407,574 | -$280.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.